Although cognitive deficits are frequently reported in GBA-PD, CSF levels of tau and β-amyloid—which are altered in patients with Alzheimer’s disease—were unchanged in GBA-PD patients (Beavan and Schapira, 2013). This evidence concerns the gene MAPT and Parkinson disease.